HP1328
HP1328 is a potent inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation) . HP1328 is a benzoimidazole scaffold-based compound. HP1328 significantly reduces the leukemia burden and prolongs the survival of mice with FLT3/ITD leukemia[1].
Product Specifications
CAS Number
[2245074-20-6]
UNSPSC
12352005
Target
FLT3
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hp1328.html
Solubility
10 mM in DMSO
Smiles
OCCOC1=CC=C(CNC2=CC(N=CN3C4=CC=CC=C4)=C3C=C2)C=C1OC
Molecular Formula
C23H23N3O3
Molecular Weight
389.45
References & Citations
[1]Tian T, et al. Identification of the Benzoimidazole Compound as a Selective FLT3 Inhibitor by Cell-Based High-Throughput Screening of a Diversity Library. J Med Chem. 2022 Feb 24;65 (4) :3597-3605.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1317923-01 0.02 mg (E-Coli)
Recombinant Pseudomonas putida Phosphatidylserine decarboxylase proenzyme (psd)
Ask
View Details 
MBS1317923-02 0.1 mg (E-Coli)
Recombinant Pseudomonas putida Phosphatidylserine decarboxylase proenzyme (psd)
Ask
View Details MBS1317923-03 0.02 mg (Yeast)
Recombinant Pseudomonas putida Phosphatidylserine decarboxylase proenzyme (psd)
Ask
View Details MBS1317923-04 0.1 mg (Yeast)
Recombinant Pseudomonas putida Phosphatidylserine decarboxylase proenzyme (psd)
Ask
View Details 
MBS1317923-05 0.02 mg (Baculovirus)
Recombinant Pseudomonas putida Phosphatidylserine decarboxylase proenzyme (psd)
Ask
View Details 
MBS1317923-06 0.02 mg (Mammalian-Cell)
Recombinant Pseudomonas putida Phosphatidylserine decarboxylase proenzyme (psd)
Ask
View Details